iNO
Showing 26 - 50 of 255
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
Dyspnea Trial (Nitric Oxide, Placebo)
Not yet recruiting
- Dyspnea
- Nitric Oxide
- Placebo
- (no location specified)
Dec 5, 2022
ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)
Not yet recruiting
- ACUTE LYMPHOBLASTIC LEUKEMIA
- Inotuzumab ozogamicin
- ALLR3
- (no location specified)
Feb 17, 2023
Prematurity, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage Trial in Chicago (inhaled nitric oxide, oxygen)
Active, not recruiting
- Prematurity
- +3 more
- inhaled nitric oxide
- oxygen
-
Chicago, IllinoisThe University of Chicago
Nov 7, 2022
Coronavirus Infection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), COVID-19 Disease Trial in Colombia, Mexico,
Active, not recruiting
- Coronavirus Infection
- +2 more
- INO-4800
- +2 more
-
Chandler, Arizona
- +26 more
Jun 9, 2022
HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
-
Los Angeles, California
- +1 more
Apr 4, 2022
Heart Transplant Surgery, Lung Transplant Surgery Trial in Durham (iNO, iEPO)
Completed
- Heart Transplant Surgery
- Lung Transplant Surgery
- iNO
- iEPO
-
Durham, North CarolinaDuke Health
Feb 14, 2022
Hypoxia Trial in Edmonton (Nitric Oxide, Placebo)
Completed
- Hypoxia
- Nitric Oxide
- Placebo
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Jul 12, 2022
Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)
Completed
- Head and Neck Cancer
- Human Papilloma Virus
- MEDI0457
- +2 more
-
San Francisco, California
- +13 more
Aug 3, 2022
Pulmonary Hypertension, Bronchopulmonary Dysplasia Trial in Orlando (inhaled nitric oxide, Placebo)
Recruiting
- Pulmonary Hypertension
- Bronchopulmonary Dysplasia
- inhaled nitric oxide
- Placebo
-
Orlando, FloridaAdventHealth
Apr 15, 2022
Pulmonary Fibrosis, Pulmonary Hypertension Trial (INOpulse)
Available
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse
- (no location specified)
Apr 26, 2022
Idiopathic Pulmonary Fibrosis Trial in Kingston (Nitric Oxide, Medical air)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Nitric Oxide
- Medical air
-
Kingston, Ontario, CanadaRespiratory Investigation Unit, Kingston General Hospital
Apr 21, 2022
Triple Negative Breast Cancer Trial (Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Seviteronel-D (Seivteronel in combination with dexamethasone)
- Docetaxel
- (no location specified)
Sep 21, 2021
InO - A Retrospective Study of UK Patients With Leukaemia
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
-
Bristol, United Kingdom
- +3 more
Jan 27, 2022
Lassa Fever Trial in Kansas City (INO-4500, Placebo, CELLECTRA® 2000)
Completed
- Lassa Fever
- INO-4500
- +2 more
-
Kansas City, MissouriThe Center for Pharmaceutical Research
Nov 20, 2020
Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)
Completed
- Head and Neck Squamous Cell Cancer
- INO-3112
- CELLECTRA™-5P
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 4, 2021
COPD Trial in Kingston (Nitric Oxide, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Nitric Oxide
- Placebo
-
Kingston, Ontario, CanadaRespiratory Investigation Unit, Kingston General Hospital
Sep 24, 2021
Pulmonary Fibrosis, Pulmonary Hypertension Trial in United States (INOpulse®, Placebo, Long Term Follow Up)
Active, not recruiting
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse®
- +2 more
-
Phoenix, Arizona
- +22 more
Feb 17, 2023
Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)
Completed
- Metastatic Castration-resistant Prostate Cancer
- NKTR-214 (Cohort A)
- +6 more
-
Los Angeles, California
- +5 more
Nov 10, 2022
Respiratory Distress Syndrome in Premature Infants, Very Low Birth Weight Baby Trial in Oklahoma City (iNO, Nitrogen)
Completed
- Respiratory Distress Syndrome in Premature Infants
- Very Low Birth Weight Baby
- iNO
- Nitrogen
-
Oklahoma City, Oklahoma
- +1 more
Aug 7, 2020
Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)
Recruiting
- Non-Tuberculous Mycobacterial Pneumonia
- +4 more
- LungFit
-
Greenslopes, Queensland, AustraliaGallipoli Medical Research Foundation
Dec 24, 2020
COPD, Pulmonary Hypertension Trial (Nitric Oxide Generation and Delivery System)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Pulmonary Hypertension
- Nitric Oxide Generation and Delivery System
- (no location specified)
Mar 14, 2023
Inhaled Nitric Oxide on Pulmonary Ventilation/Perfusion Ratio
Recruiting
- Critical Illness
-
Wuhan, Hubei, ChinaHongling Zhang
May 15, 2023
COPD Trial (Nitric Oxide Generation and Delivery System)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Nitric Oxide Generation and Delivery System
- (no location specified)
Jun 1, 2023